Eye Disease News and Research

RSS
Eye diseases are widespread around the globe. According to the World Health Organization, the most important three eye diseases or conditions that are a potential threat to the global population are diabetic retinopathy, glaucoma, and age-related macular degeneration. One more vital reason for visual harm is refractive errors. Some of the important reasons for vision loss or low vision are age, healthcare, gender, genetic problems and the prevalence of family history.
New mobile app can help people diagnosed with glaucoma

New mobile app can help people diagnosed with glaucoma

Study sheds light on the recurrence of herpes simplex virus

Study sheds light on the recurrence of herpes simplex virus

UIC researchers receive $10.15 million grant to develop treatment for dry eye conditions

UIC researchers receive $10.15 million grant to develop treatment for dry eye conditions

Why even presidential pressure might not get more vaccine to market faster

Why even presidential pressure might not get more vaccine to market faster

Scientists discover genetic variations that have a drastic impact on small molecules

Scientists discover genetic variations that have a drastic impact on small molecules

Large study provides new understanding of genome diversity in Ukrainian population

Large study provides new understanding of genome diversity in Ukrainian population

AI screening algorithms to diagnose diabetic retinopathy do not show consistent performance

AI screening algorithms to diagnose diabetic retinopathy do not show consistent performance

Routine eye imaging may provide clues to cognitive disorders in older people with type 1 diabetes

Routine eye imaging may provide clues to cognitive disorders in older people with type 1 diabetes

New data shows encouraging results for patients with neuro-degenerative blinding eye disease

New data shows encouraging results for patients with neuro-degenerative blinding eye disease

Surgical and drug treatment approaches are equally effective for diabetic eye disease

Surgical and drug treatment approaches are equally effective for diabetic eye disease

Study offers new clues to the pathogenesis of glaucoma

Study offers new clues to the pathogenesis of glaucoma

Researchers develop potential non-drug, non-surgical, long-acting therapy for glaucoma

Researchers develop potential non-drug, non-surgical, long-acting therapy for glaucoma

Study: Global public health services fail to meet targets to reduce avoidable sight loss

Study: Global public health services fail to meet targets to reduce avoidable sight loss

Studies examine rates of blindness and vision impairment worldwide

Studies examine rates of blindness and vision impairment worldwide

New gene therapy approach offers promise for treating eye disease

New gene therapy approach offers promise for treating eye disease

Common medication used to treat diabetic macular edema is less effective in Black patients

Common medication used to treat diabetic macular edema is less effective in Black patients

Researchers create multi-functional nano-vaccine to prevent toxoplasmosis

Researchers create multi-functional nano-vaccine to prevent toxoplasmosis

FDA awards six clinical trial research grants to enhance development of therapies for rare diseases

FDA awards six clinical trial research grants to enhance development of therapies for rare diseases

First pathoconnectome shows how eye disease alters retinal circuitry

First pathoconnectome shows how eye disease alters retinal circuitry

Study reveals how people with retinal degenerative disease can maintain night vision

Study reveals how people with retinal degenerative disease can maintain night vision

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.